Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Florian, Lüke"'
Autor:
Christine, Bernardi, Daniel, Wolff, Florian, Lüke, Johannes, Hies, Nina, Hallowell, Ruth, Horn, Frederike, Seitz, Daniel, Heudobler, Anne, Hermann-Johns
Publikováno v:
In Patient Education and Counseling May 2024 122
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/5109a0f2314e4629ae8608dc6e633b31
Autor:
Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop, Lina Ghibelli, Christopher Gerner, Albrecht Reichle, Daniel Heudobler
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
A series of seven clinical trials on relapsed or refractory (r/r) metastatic neoplasias followed the question: Are networks of ligand-receptor cross-talks that support tumor-specific cancer hallmarks, druggable with tumor tissue editing approaches th
Externí odkaz:
https://doaj.org/article/bf03ea496d9b4c92934b5b16e11cb96b
Autor:
Matthias A. Fante, Dennis C. Harrer, Barbara Zartner, Florian Lüke, Stephanie Mayer, Karin Menhart, Albrecht Reichle, Wolfgang Herr, Martin Vogelhuber, Daniel Heudobler
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposePeripheral T-cell lymphoma (PTCL) is a rare and heterogenous hematologic malignancy with poor prognosis especially in elderly and frail patients who are not eligible for intensive treatment. The resulting palliative setting necessitates tolera
Externí odkaz:
https://doaj.org/article/e088df970cad4128946c8c59a3664e32
Autor:
Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop, Lina Ghibelli, Albrecht Reichle, Daniel Heudobler
Publikováno v:
Cancers, Vol 16, Iss 1, p 180 (2023)
The concept of post-therapy metastatic spread, cancer repopulation and acquired tumor cell resistance (M-CRAC) rationalizes tumor progression because of tumor cell heterogeneity arising from post-therapy genetic damage and subsequent tissue repair me
Externí odkaz:
https://doaj.org/article/55160e1a963747ec87946dc8671269e2
Autor:
Sarah M. Hücker, Tobias Fehlmann, Christian Werno, Kathrin Weidele, Florian Lüke, Anke Schlenska-Lange, Christoph A. Klein, Andreas Keller, Stefan Kirsch
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Technologies for small non-coding RNA sequencing at the single-cell level are less mature than for sequencing mRNAs. Here the authors evaluate available protocols for analysis of circulating lung cancer tumour cells.
Externí odkaz:
https://doaj.org/article/b7aaf42d26034da3865f132170e16835
Autor:
Florian Lüke, Dennis Christoph Harrer, Pan Pantziarka, Tobias Pukrop, Lina Ghibelli, Christopher Gerner, Albrecht Reichle, Daniel Heudobler
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The combinatory use of drugs for systemic cancer therapy commonly aims at the direct elimination of tumor cells through induction of apoptosis. An alternative approach becomes the focus of attention if biological changes in tumor tissues following co
Externí odkaz:
https://doaj.org/article/e9cddf90b49d4395930e3c6b358fab04
Autor:
Dennis Christoph Harrer, Florian Lüke, Ingo Einspieler, Karin Menhart, Dirk Hellwig, Kirsten Utpatel, Wolfgang Herr, Albrecht Reichle, Daniel Heudobler
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundAcute promyelocytic leukemia (APL) constitutes a serious hematological emergency necessitating rapid diagnosis and therapy to prevent lethal bleedings resulting from APL-induced thrombocytopenia and coagulopathy. Atypical manifestations of
Externí odkaz:
https://doaj.org/article/e16b3b19e9824c9b843c5224f9f7e1a5
Autor:
Alexander Scheiter, Felix Keil, Florian Lüke, Jirka Grosse, Niklas Verloh, Sabine Opitz, Sophie Schlosser, Arne Kandulski, Tobias Pukrop, Wolfgang Dietmaier, Matthias Evert, Diego F. Calvisi, Kirsten Utpatel
Publikováno v:
Current Oncology, Vol 28, Iss 2, Pp 1161-1169 (2021)
Fibroblast growth factor receptor 2 (FGFR2) fusions have emerged as a new therapeutic target for cholangiocarcinoma in clinical practice following the United States Food and Drug Administration (FDA) approval of Pemigatinib in May 2020. FGFR2 fusions
Externí odkaz:
https://doaj.org/article/f2ad679a909f4daf81e62e6f9b6cc0ab
Autor:
Matthias Lubnow, Barbara Schmidt, Martin Fleck, Bernd Salzberger, Thomas Müller, Georg Peschel, Roland Schneckenpointner, Tobias Lange, Florian Hitzenbichler, Martin Kieninger, Dirk Lunz, Bernhard Graf, Christoph Brochhausen, Florian Weber, Florian Lüke, David Peterhoff, Philipp Schuster, Andreas Hiergeist, Robert Offner, Ute Hehr, Stefan Wallner, Frank Hanses, Stephan Schmid, Kilian Weigand, Florian Geismann, Hendrik Poeck, Tobias Pukrop, Matthias Evert, Andre Gessner, Ralph Burkhardt, Wolfgang Herr, Lars S. Maier, Daniel Heudobler
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss , Pp 624-627 (2021)
A 21-year-old woman was hospitalized due to coronavirus disease 2019 (COVID-19)-associated respiratory and hepatic impairment concomitant with severe hemolytic anemia. Upon diagnosis of secondary hemophagocytic lymphohistiocytosis, immunosuppression
Externí odkaz:
https://doaj.org/article/1e6ad5d41aa74c868cb07ceeb8722c90